Infusion pumps – new study showing you trends, R&D progress, and predicted revenues
Where is the infusion pumps market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.
Our 216-page report provides 127 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing medical devices market.
Forecasts from 2014-2024 and other analyses show you commercial prospects
Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter’s Five Forces Analysis), leading products, competing technologies and commercial developments.
Read the full transcripts of an exclusive interview with Professor Charles Clark, Former Associate Dean at Indiana University School of Medicine, and current medical director of two diabetes centres in two major Chinese Hospitals.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2024 for these three submarkets:
• Insulin pumps
• Enteral feeding pumps
• Other infusion pumps, including chemotherapy an PCA pumps
With our investigation you gain business research and analysis with individual sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints affecting each submarket. See what's likely to achieve the most success.
You gain competitive advantages by understanding the dynamics, opportunities and challenges facing the infusion pumps market.
Our analysis also breaks down the submarkets by geography to derive the national market share within each submarket.
What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you discover individual revenue forecasts for 12 national markets to 2024:
• US
• Japan
• China
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• India
• Brazil
• Russia
• South Korea
• Rest of the World
There will be growth in established and developing medical devices markets. Our analyses show that India, China, South Korea and Brazil, in particular, will continue to achieve high revenue growth to 2024. Developments worldwide in product approval and patient demographics will influence the infusion pumps market.
There exist many opportunities for medical device companies developing infusion pump technologies. You can assess the industry's future – hear about developments and find their significance in our analytical report.
See revenue forecasts for competing drug delivery technologies
How will competing drug delivery technologies perform to 2024 at world level? Our study forecasts the sales revenue of global drug delivery technologies market as well as the submarkets by application for the period 2014-2024. Submarkets included in the forecast are:
• Oral drug delivery
• Inhalation drug delivery
• Injectable/ implants drug delivery
• Transdermal drug delivery
• Ocular drug delivery
• Nasal drug delivery
Discover how high revenues can go. You see what's happening, understanding trends, challenges and opportunities.
Leading products and companies
What will happen next? We predict the overall world market for infusion pumps will reach $8.20bn in 2015, and expand further to 2024.
Our study shows you what technologies, products and companies hold greatest potential. The report contains reviews of 32 leading infusion pumps on the market and their manufacturing companies.
From 2014 to 2024, many opportunities will arise. Our work shows you the technological and commercial possibilities, helping you stay ahead.
Research and development – assess innovation, trends and possibilities
What about R&D – the pipeline for new infusion pumps? You will see further 15 pipeline products currently under development by big players in the infusion pumps market
Our study also discusses key R&D pipeline for narcotic pain relieving drugs, which are often used in PCA infusion therapies, as well as the pipeline for drug delivery technologies by application.
Insulin pumps are currently the most dynamic submarket within the infusion pumps market in terms of its wealth of technological innovations and R&D pipeline. Cost-effective, safe and portable pumps are in great demand. We see the next generation of new smart pumps dictating the infusion pumps market in the years to come.
What issues will affect the infusion pumps market?
Our new report discusses issues and events affecting the infusion pumps market from 2014, looking ahead. You will find discussions, including qualitative analyses:
• Shifting dynamics in the infusion pumps market
• Escalating levels of worldwide chronic diseases including diabetes and cancer
• Reimbursement outlook in key segments of the market
• Strengths and weaknesses of the infusion pumps market
• The microenvironment in which companies operate
Also, you find coverage of these aspects:
• New European Medical Devices Regulations
• Competition from pharmaceuticals and other drug delivery technologies
• Regulatory harmonisation across major international markets
• Expanding healthcare coverage in emerging markets
You will see discussions of technological, commercial, economic and political matters, with emphasis on the competitive landscape and business outlooks.
How the Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies report helps you
In summary, our new 219-page comprehensive report gives you the following knowledge:
• Revenues forecast to 2024 for the world infusion pumps market and submarkets– discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2024 for the leading 12 national markets – US, Japan, China, Germany, France, UK, Italy, Spain, Rest of Europe, India, Brazil, Russia, South Korea and Rest of the World
• Reviews of 32 leading infusion pumps on the market – hear about products, results and strategies.
• Review of 15 pipeline products under development – investigate developmental trends and progress
• Revenue forecasts to 2024 of competing drug delivery technologies – you find activities, products, capabilities and outlooks
• Discussion of what stimulates and restrains the industry and market – you assess challenges and strengths
• Understanding of competition and opportunities – you see what affects that industry, learning what shapes its future
• Analysis of microenvironment – helping you compete and gain advantages
• Prospects for established firms and those seeking to enter the market – you explore needs, practices and outlooks for success
• View interview transcripts with a market expert – gain exclusive market insights
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
We give independent analysis from our primary and secondary research. You will receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.
With our report you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions, saving you time and getting you recognition for commercial insight.
Discover technological and commercial prospects from 2014 by ordering now
Visiongain's study is for everyone needing analysis of the industry and market for infusion pumps. You find data, trends and predictions. Please ask for our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 World Infusion Pumps Market Highlights
1.2 World Infusion Pumps Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Infusion Pumps
2.1 What is an Infusion Pump?
2.2 Types of Infusion
2.3 Types of Pumps
2.3.1 Gravity Controlled Pumps
2.3.2 Positive Displacement Pumps
2.3.2.1 Drip Rate Pumps
2.3.2.2 Volumetric Pumps
2.3.2.3 Syringe Pumps
2.3.2.4 Multi-Channel Pumps
2.3.2.5 Ambulatory Pumps
2.4 History of Infusion Pumps
2.5 What Clinical Settings Will Infusion Pumps be Useful?
2.5.1Infusion Pumps for Diabetes
2.5.2 Infusion Pumps for Chemotherapy
2.5.3 Infusion Pumps for Analgesia
2.5.4 Infusion Pumps for Enteral Feeding
2.5.5 Other Uses for Infusion Pumps
2.6 Advantages and Disadvantages of Infusion Pumps
2.7 Regulation of the Infusion Pump Market
2.7.1The US Approval and Regulation System
2.7.2 The EU Approval and Regulation System
2.7.2.1Expected Changes in the New EU Medical Device Regulations
2.7.2.2 When Will the Changes be Finalised?
2.7.2.3 Post Marketing Surveillance in the EU
2.8 Infusion Pump Market Definition
3. Infusion Pumps: World Market 2014-2024
3.1 World Medical Devices Market 2013-2023
3.2 World Infusion Pumps Market 2013
3.3 World Infusion Pumps Market: Sales Forecast 2014-2024
3.3.1 The Infusion Pups Market: Sales Forecast 2013-2018
3.3.2 The Infusion Pups Market: Sales Forecast 2018-2024
3.4 Insulin Pumps Lead the World Speciality Infusion Pumps Market
3.5 How Will Segmental Market Shares Change to 2024?
3.6 World Infusion Pumps Market: Drivers and Restraints 2014-2024
3.6.1 Ageing Population and Rising Incidences of Chronic Diseases
3.6.2 Advancement in Infusion Pump Technologies
3.6.3 A Shift Towards Home Care
3.6.4 Safety Risk and Stringent Approval Process
4. Leading National Markets 2014-2024
4.1 Regional Breakdown of World Infusion Pumps Market 2013
4.2 Infusion Pumps National Market Forecast 2014-2024
4.2.1 How Will National Market Shares Change to 2024?
4.3 US Infusion Pumps Market 2013
4.3.1 US Infusion Pumps Market Forecast 2014-2024
4.3.2 US Infusion Pumps Market: Trends and Developments
4.3.2.1 Ageing Population and Increase Prevalence of Diabetes
4.3.2.2 HITECH Act: Increase Medical Technology Innovations
4.3.2.3 FDA Infusion Pumps Recall
4.3.2.4 Effects of the US Medical Device Excise Tax
4.3.2.5 Hospital Readmission Reduction Program: Increase Demand for Homecare
4.4 European Infusion Pumps Market 2013
4.4.1 European Infusion Pumps Market forecast 2014-2024
4.4.1.1 How Will European Market Shares Change to 2024?
4.4.2 Europe Infusion Pumps Market: Trends and Developments
4.4.2.1 New EU Medical Device Regulations: Potential Impact on Manufacturers
4.4.3 Germany Infusion Pumps Market Forecast 2014-2024
4.4.3.1 German Infusion Pumps Market: Trends and Developments
4.4.4 French Infusion Pumps Market Forecast 2014-2024
4.4.4.1 French Infusion Pumps Market: Trends and Developments
4.4.5 UK Infusion Pumps Market Forecast 2014-2024
4.4.5.1 UK Infusion Pumps Market: Trends and Developments
4.4.6 Italian Infusion Pumps Market Forecast 2014-2024
4.4.6.1 Italian Infusion Pumps Market: Trends and Developments
4.4.7 Spanish Infusion Pumps Market Forecast 2014-2024
4.4.7.1 Spanish Infusion Pumps Market: Trends and Developments
4.5 Japanese Infusion Pumps Market 2013
4.5.1 Japanese Infusion Pumps Market Forecast 2014-2024
4.5.2 Japanese Infusion Pumps Market: Trends and Developments
4.5.2.1 Improved Approval Process
4.5.2.2 The Cost of Treatment in Japan
4.6 Chinese Infusion Pumps Market 2013
4.6.1 Chinese Infusion Pumps Market Forecast 2014-2024
4.6.2 Chinese Infusion Pumps Market: Trends and Developments
4.6.2.1 China’s 12th Five-Year-Plan (2010-2015)
4.6.2.2 New Policies Favouring Domestically-Made Medical Devices
4.7 Indian Infusion Pumps Market 2013
4.7.1 Indian Infusion Pumps Market Forecast 2014-2024
4.7.2 Indian Infusion Pumps Market: Trends and Developments
4.7.2.1 Improved Standard Regulatory Structure
4.7.2.2 Expansion of Healthcare Provision
4.8 Brazilian Infusion Pumps Market 2013
4.8.1 Brazilian Infusion Pumps Market Forecast 2014-2024
4.8.2 Brazilian Infusion Pumps Market: Trends and Developments
4.8.2.1 Challenges within the Brazilian Medical Devices Market
4.9 South Korean Infusion Pumps Market 2013
4.9.1 South Korean Infusion Pumps Market Forecast 2014-2024
4.9.2 South Korean Infusion Pumps Market: Trends and Developments
4.9.2.1 Expansion of South Korean Medical Devices Market
4.10 Russian Infusion Pumps Market 2013
4.10.1 Russian Infusion Pumps Market Forecast 2014-2024
4.10.2 Russian Infusion Pumps Market: Trends and Developments
4.10.2.1 Russian Healthcare Development Plan 2013-2020
4.10.2.2 New Russian Medical Devices Regulations 2014
5. Insulin Pumps Submarket 2014-2024
5.1 Introduction to Insulin Pumps
5.1.1 The Dosing of Insulin in Insulin Pumps
5.1.1.1 Bolus Infusion
5.1.1.2 Basal Infusion
5.1.2 The Advantages and Disadvantages of Insulin Pumps
5.1.3 Human Insulin and analogues Primarily Used in Insulin Pumps
5.2 Insulin Infusion Pumps Submarket 2013
5.2.1 Insulin Pumps Submarket Regional Breakdown 2013
5.3 Insulin Pumps Submarket: Sales Forecast 2014-2024
5.3.1 Insulin Pumps Submarket: Sales Forecast 2013-2018
5.3.2 Insulin Pumps Submarket: Sales Forecast 2018-2024
5.4 Leading Products in Insulin Pumps Submarket 2014
5.4.1 OmniPod (Insulet Corporation)
5.4.2 MiniMed Paradigm (Medtronic)
5.4.3 OneTouch Ping (Animas Corporation)
5.4.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
5.4.5 t:Slim (Tandem Diabetes Care)
5.4.6 Asante Snap (Asante Solutions)
5.4.7 DANA Diabecare IISG (SOOIL)
5.4.8 SpringZone (D. Medical Industries)
5.4.9 Cellnovo (Cellnovo)
5.4.10 V-Go (Valeritas)
5.5 Key Insulin Pumps Pipeline Products 2014
5.5.1 Finesse Personal Insulin Patch (Johnson & Johnson)
5.5.2 SOLO MicroPump (Roche)
5.5.3 JewelPump (Debiotech)
5.5.4 Artificial Pancreas (Juvenile Diabetes Research Foundation)
5.5.5 PaQ (CeQur)
5.5.6 t:Sensor & t:Flex (Tandem Diabetes Care)
5.5.7 Animas Vibe (Johnson & Johnson)
5.5.8 Freehand (MedSolve Technologies)
5.5.9 NanoPump (Debiotech)
5.5.10 PassPort (Altea Therapeutics)
5.5.11 NiliPatch (D.Medical Industries)
5.6 Insulin Pumps Submarket: Drivers and Restraints 2014-2024
5.6.1 New Entrants Fuel Innovative Technologies
5.6.2 Collaborations Advance Innovations to Address Unmet Need in Artificial Pancreas Systems
5.6.3 Strong R&D Pipeline
5.6.4 Rapid Increase in Prevalence of Diabetes Worldwide
5.6.5 Increasing Acceptance of Insulin Pumps in Developed Economies
5.6.6 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits
5.6.7 More Expensive Insulin Infusion Therapy Limit Its Successful Penetration in Emerging Markets
5.6.8 Security Risks with Insulin Pumps
5.7 Concluding Remarks
6. Enteral Feeding Pumps Submarket 2014-2024
6.1 Introduction to Enteral Feeding Pumps
6.1.1 Clinical Settings That May Require Enteral Feeding
6.1.2 Advantages and Disadvantages of Enteral Feeding
6.1.3 Delivery of Enteral Feeding
6.1.3.1 Tube Placements Used in Enteral Feeding
6.1.4 Enteral Feeding at Home
6.2 Enteral Feeding Pumps Submarket 2013
6.2.1 Enteral Feeding Pumps Submarket Regional Breakdown 2013
6.3 Enteral Feeding Pumps Submarket: Sales Forecast 2014-2024
6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast 2013-2018
6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast 2018-2024
6.4 Leading Products in Enteral Feeding Pump Submarket 2014
6.4.1 Compat DualFlo Enteral Feeding Pump (Nestle)
6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
6.4.3 EnteraLite Infinity Enteral Feeding Pump (Moog)
6.4.4 APPLIX Vision (Fresenius Kabi)
6.4.5 MiniFlo (Fresenius Kabi)
6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia)
6.4.7 Sapphire (Q Core Medical)
6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
6.4.9 Other Notable Enteral Feeding Pumps
6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints 2014-2024
6.5.1 Development of Cost-Effective, Increased Safety and Technologically Advanced Products
6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases
6.5.3 Increasing Demand for Homecare Solutions and Portability
6.5.4 Exit to Abbott in the US Enteral Feeding market in 2013
6.5.5 Introduction of ISO’s Standards for Small-Bore Connectors
6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market Revenue
6.5.7 Highly Competitive Market with High Barriers to Entry
6.6 Concluding Remarks
7. Other Infusion Pumps Submarket 2014-2024
7.1 Other Infusion Pumps Submarket Definition
7.2 Other Infusion Pumps Submarket 2013
7.3 Other Infusion Pumps Submarket: Sales Forecast 2014-2024
7.4 Chemotherapy Pumps
7.4.1 Introduction to Chemotherapy Pumps
7.4.2 Advantages and Disadvantages of Chemotherapy Pumps
7.4.3 Leading Drugs in the Cancer Therapeutics Market 2014
7.4.4 Current State of Chemotherapy Pumps Market 2014
7.4.5 Leading Products in Chemotherapy Pumps Market 2014
7.4.5.1 Infusor Infusion Pump (Baxter)
7.4.5.2 CODMAN 3000 (Johnson & Johnson)
7.4.5.3 Optima MS (Fresenius Kabi)
7.4.5.4 CADD Legacy-1 (Smiths Medical)
7.4.5.5 Other Notable Chemotherapy Pumps
7.4.6 Key Chemotherapy Pumps Pipeline Products 2014
7.4.6.1 Metronomic Biofeedback Pump (Pharmaco-Kinesis Corporation)
7.4.7 Chemotherapy Pumps Market: Drivers and Restraints 2014-2024
7.4.8 Concluding Remarks
7.5 Patient Controlled Analgesia Pumps
7.5.1 Introduction to Patient Controlled Analgesia
7.5.1.1 What are PCA Pumps?
7.5.1.2 How Does a PCA Pump Work?
7.5.1.3 Clinical Settings Where PCA Pumps are Used
7.5.1.4 Advantages and Disadvantages of PCA Pumps
7.5.2 Leading Drugs in the Pain Relief Market
7.5.2.1 Narcotic Drugs
7.5.2.2 World Narcotic Pain Relieving Drugs Market: Sales forecast 2014-2024
7.5.3 Current State of PCA Pumps Market 2014
7.5.4 Leading Products in the PCA Pumps Market 2014
7.5.4.1 LifeCare PCA with Hospira MedNet Software (Hospira)
7.5.4.2 GemStar Infusion Pump System (Hospira)
7.5.4.3 Alaris PCA (CareFusion)
7.5.4.4 Baxter PCA II (Baxter)
7.5.4.5 Curlin PainSmart IOD Pain Management System (B.Braun)
7.5.4.6 Perfusor Space PCA Infusion Pump (B.Braun)
7.5.4.7 CADD-Solis Infusion Pump (Smiths Medical)
7.5.4.8 Other Notable PCA Pumps
7.5.5 Key PCA Infusion Pump Pipeline Products 2014
7.5.5.1 MIP (Debiotech)
7.5.6 PCA Pumps Market: Drivers and Restraints 2014-2024
7.5.7 Concluding Remarks
8. Competing Technology Analysis 2014-2024
8.1 Drug Delivery Technologies
8.1.1 Introduction to Drug Delivery Technologies (DDT)
8.1.2 Types of Technologies for Drug Delivery
8.1.2.1 Sustained/Controlled Release Systems
8.1.2.2 Injection
8.1.2.3 Needle Free Injections
8.1.2.4 Pulmonary, Buccal and Nasal Delivery
8.1.2.5 Pills and Capsules
8.2 World Drug Delivery Technologies Market 2013
8.2.1 Drug Delivery Technologies Market Regional Breakdown 2013
8.3 World Drug Delivery Technologies Market Forecast 2014-2024
8.4 Key Drug Delivery Pipeline Products 2014
8.5 Concluding Remarks
9. Qualitative Analysis of the Infusion Pumps Market 2014-2024
9.1 SWOT Analysis of World Infusion Pumps Market 2014-2024
9.2 Strengths
9.2.1 Pumpers Have Improved Quality of Life and Less Hospital Visits
9.2.2 Highly Accurate Dosing at Regular Intervals
9.2.3 Usage in a Wide Range of Clinical Settings
9.3 Weaknesses
9.3.1 Expensive Technologies May Restrain the Market
9.3.2 Safety Concerns Will Act to Restrain the Market
9.3.3 Pumps are Cumbersome and May Discourage Potential Users
9.4 Opportunities
9.4.1 Off-Patent Drugs Will Help to Drive the Market
9.4.2 Higher Growth in Emerging Economies
9.4.3 Technological Advancement Opens New Market Opportunities
9.4.4 Patient Demographics
9.5 Threats
9.5.1 Novel Drug Delivery Systems May be Cheaper and More Effective
9.5.2 Regulatory Authorities are Reluctant to Take Risks
9.5.3 Cost Effectiveness May be Difficult to Prove
9.5.4 Poor Macroeconomic Conditions in Key Regions of the Market
9.5.5 Increasing Bargaining Power of Buyers
9.6 Porter’s Five Force Analysis of the Infusion Pumps Market
9.6.1 Rivalry Among Competitors [High]
9.6.2 Threat of New Entrants [Medium]
9.6.3 Power of Suppliers [Medium]
9.6.4 Bargaining Power of Buyers [High]
9.6.5 Threat of Substitutes [Medium]
10. Research Interviews
10.1 Interview with Prof. Charles Clark, Former Associate Dean at Indiana University School of Medicine
10.1.1 New Glucose-Analysing Programme
10.1.2 Restraints in the Chinese Insulin Pumps Market
10.1.3 Market Potentials in the Insulin Pumps Market
10.1.4 Opportunities for Infusion Pumps Manufacturers
10.1.5 Size of the Current Chinese Insulin Pumps Market
10.1.6 Challenges Facing Infusion Pumps Manufacturers in Emerging Economies
10.1.7 The Future of Insulin Pumps Market?
11. Conclusions
11.1 Infusion Pumps: A Growing Specialist Market
11.2 The World Infusion Pumps Market 2014
11.2.1 Leading Infusion Pumps Submarkets 2014
11.2.2 Leading Infusion Pump Products 2014
11.2.3 Leading National Markets 2014
11.3 Infusion Pumps Pipeline Products 2014
11.4 World Infusion Pump Market: Consistent Growth Over 2014-2024
11.5 The Future of the Infusion Pumps Market?
11.5.1 Safety Concerns &Stringent Regulations Will Continue to Restrain the Market
11.5.2 Trend Towards Pumps Usage in Homecare Settings
11.5.3 What Will Succeed in the Infusion Pumps Market?
List of Tables
Table 1.1 Leading National Infusion Pumps Market Forecast 2013-2024 ($bn, AGR%)
Table 2.1 Ideal Specification of an Infusion Pump
Table 2.2 Specification of a Syringe Pump
Table 2.3 Ideal Specification of an Infusion Pump
Table 2.4 Advantages and Disadvantages of Infusion Pumps
Table 3.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%),CAGR (%), 2012-2023
Table 3.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 3.3 Market Shares (%) of Infusion Pumps Market Segment 2013, 2018 and 2024
Table 4.1 Global Infusion Pumps Market: Revenues ($bn) and Market Shares (%) by Region, 2013
Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Region, 2013-2024
Table 4.3 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2013-2018, 2018-2024 and 2013-2024
Table 4.4 Market Shares (%) of Infusion Pumps Market by Region, in 2013, 2018 and 2024
Table 4.5 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.6 European Infusion Pumps Market: Revenues ($bn) and European Market Shares (%) by Leading Countries, 2013
Table 4.7 European Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.8 European Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2013-2018, 2018-2024 and 2013-2024
Table 4.9 European Market Shares (%) of the European Infusion Pumps Market by Leading Countries, in 2013, 2018 and 2024
Table 4.10 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.11 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.13 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.14 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.15 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.16 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.17 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.18 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.19 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.20 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.1 Advantages and Disadvantages of Insulin Pumps
Table 5.2 Insulin Analogues Submarket: Revenue ($bn) and Market Shares (%) by Leading Products, 2013
Table 5.3 Insulin Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2013
Table 5.4 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.5 Leading Products in the Insulin Pumps Submarket, 2014
Table 5.6 Key Pipeline Products for Insulin Pumps Submarket, 2014
Table 5.7 Diabetes Prevalence (m) in Leading National Markets, 2013
Table 6.1 Types of Tubes Used in Enteral Feeding
Table 6.2 Enteral Feeding Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2013
Table 6.3 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.4 Leading Products in the Enteral Feeding Pumps Submarket, 2014
Table 7.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.2 Advantages and Disadvantages of Chemotherapy Pumps
Table 7.3 Top 10 Anti-Cancer Drugs: Revenue ($bn) and Market Shares (%), 2013
Table 7.4 Top 10 Anti-Cancer Drugs: Key Facts
Table 7.5 Leading Products in the Chemotherapy Pump Market, 2014
Table 7.6 Advantages and Disadvantages of PCA Pumps
Table 7.7 World Narcotic Pain Relieving Drugs Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.8 Leading Products in the PCA Pumps Market, 2014
Table 7.9 Key Pipeline for Narcotic Pain Relieving Drugs, 2014
Table 8.1 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Application, 2013
Table 8.2 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Country, 2013
Table 8.3 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Application, 2013-2024 (Biannual)
Table 8.4 Key Pipeline Products for Drug Delivery Technologies, 2014
Table 9.1 SWOT Analysis of World Infusion Pumps Market 2014-2024
Table 9.2 Average Initial Costs Associated With Insulin Pump Use ($)
Table 9.3 Insulin Delivery Technologies: Average Annual Costs of Usage ($)
Table 9.4 Chinese and Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2013-2024
Table 9.5 Infusion Pumps and Related Products Recall in the US, 2007-2014
Table 11.1 Leading Infusion Pumps by Type in 2014
Table 11.2 Infusion Pumps Pipeline Products by Type in 2014
List of Figures
Figure 1.1 World 65+ Population Forecast: Size (m), CAGR (%), by National Market, 2013-2024
Figure 1.2 World Infusion Pumps Market Segmentation Overview, 2014
Figure 2.1 Revision of the Medical Devices Directives
Figure 3.1 Medical Devices Market Forecast: Revenue ($bn), AGR (%), 2013-2023
Figure 3.2 World Infusion Pumps Market Forecast: Revenue ($bn), AGR (%), 2013-2024
Figure 3.3 World Infusion Pumps Market: Revenues ($bn) by Segment, 2013-2024
Figure 3.4 World Infusion Pumps Market Forecast: Revenue ($bn), CAGR (%), by Segment, in 2013 and 2024
Figure 3.5 World Infusion Pumps Market: Market Shares (%) by Segment, 2013
Figure 3.6 World Infusion Pumps Market: Market Shares (%) by Segment, 2018
Figure 3.7 World Infusion Pumps Market: Market Shares (%) by Segment, 2024
Figure 3.8 World Infusion Pumps Market: Drivers and Restraints, 2014-2024
Figure 4.1 World Infusion Pumps Market: Revenues ($bn) by Region, 2013
Figure 4.2 World Infusion Pumps Market: Market Shares (%) by Region, 2013
Figure 4.3 World Infusion Pumps Market: Revenues ($bn) by Region, 2013-2024
Figure 4.4 World Infusion Pumps Market Forecast: Revenue ($bn), CAGR (%), by Region, in 2013 and 2024
Figure 4.5 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2013-2018, 2018-2024 and 2013-2024
Figure 4.6 World Infusion Pumps Market: Market Shares (%) by Region, 2018
Figure 4.7 World Infusion Pumps Market: Market Shares (%) by Product, 2024
Figure 4.8 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.9 US 65+ Population Forecast: Size (m), 2013-2024
Figure 4.10 European Infusion Pumps Market: Revenue ($bn) by Leading Countries, 2013
Figure 4.11 European Infusion Pumps Market: European Market Shares (%) by Leading Countries, 2013
Figure 4.12 European Infusion Pumps Market Forecast: Revenue ($bn), AGR (%), 2013-2024
Figure 4.13 European Infusion Pumps Market Forecast: Revenues ($bn) by Leading Countries, 2013-2024
Figure 4.14 European Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2013-2018, 2018-2024 and 2013-2024
Figure 4.15 European Infusion Pumps Market: European Market Shares (%) by Leading Countries, 2018
Figure 4.16 European Infusion Pumps Market: European Market Shares (%) by Leading Countries, 2024
Figure 4.17 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.18 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.19 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.20 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.21 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.22 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.23 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.24 China’s Historical Healthcare Expenditure ($bn), 2001-2010
Figure 4.25 Chinese Population: Aged 65 or Over (million) in 1950, 2010 and 2050
Figure 4.26 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.27 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.28 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 4.29 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), 2013-2024
Figure 5.1 Insulin Analogues Submarket: Revenue ($bn) by Leading Products, 2013
Figure 5.2 Insulin Analogues Submarket: Market Shares (%) by Leading Products, 2013
Figure 5.3 Insulin Pumps Submarket: Revenues ($bn) by Region, 2013
Figure 5.4 World Infusion Pumps Market: Market Shares (%) by Submarket and Submarket Region, 2013
Figure 5.5 Insulin Pumps Submarket Forecast: Revenue ($bn), AGR (%), 2013-2024
Figure 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2014-2024
Figure 5.7 Diabetes Prevalence (%) in Leading National Markets, 2014
Figure 6.1 Enteral Feeding Pumps Submarket: Revenues ($bn) by Region, 2013
Figure 6.2 World Infusion Pumps Market: Market Shares (%) by Submarket and Region, 2013
Figure 6.3 Enteral Feeding Pumps Submarket Forecast: Revenue ($bn), AGR (%), 2013-2024
Figure 6.4 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2014-2024
Figure 7.1 Other Infusion Pumps Submarket Forecast: Revenue ($bn), AGR (%), 2013-2024
Figure 7.2 Top 10 Anti-Cancer Drugs: Revenues ($bn), 2013
Figure 7.3 Top 10 Anti-Cancer Drugs: Market Shares (%), 2013
Figure 7.4 Chemotherapy Pumps World Market: Drivers and Restraints, 2014-2024
Figure 7.5 World Narcotic Pain Relieving Drugs Market Forecast: Revenue ($bn), AGR (%), 2013-2024
Figure 7.6 PCA Pumps World Market: Drivers and Restraints, 2014-2024
Figure 8.1 World Drug Delivery Technologies Market: Revenues ($bn) by Application, 2013
Figure 8.2 World Drug Delivery Technologies Market: Market Shares (%) by Application, 2013
Figure 8.3 World Drug Delivery Technologies Market: Revenues ($bn) by Country, 2013
Figure 8.4 World Drug Delivery Technologies Market: Market Shares (%) by Country, 2013
Figure 8.5 World Drug Delivery Technologies Market Forecast: Revenue ($bn), AGR (%), 2013-2024 (Biannual)
Figure 8.6 World Drug Delivery Technologies Market Forecast: Revenue ($bn) by Application, 2013-2024 (Biannual)
Figure 9.1 Insulin Delivery Technologies: Average Annual Costs of Usage ($)
Figure 9.2 Chinese and Indian Infusion Pumps Market Forecast: Revenue ($bn), 2013-2024
Figure 9.3 World Population Aged 65+ Forecast: Population (millions), AGR (%), 2013-2024
Figure 9.4 Porter’s Five Forces Analysis of the Infusion Pumps Market, 2014-2024
Figure 11.1 Top Five National Infusion Pumps Market: Revenues ($bn), 2014 & 2024
Abbott Nutrition
AcelRx Pharmaceuticals
Acura
Akas Medical
ALCOR Scientific
Alkemes
Allied Medical
Altea Therapeutics
Amsino International
Animas (acquired by Johnson & Johnson)
Aradigm
Asante Solutions
B. Braun
Baxter
Bayer Healthcare
Becton & Dickson Co
Biodelivery Sciences
Biomed
Boston Scientific
Bristol-Myers Squibb
Calibra Medical (acquired by Johnson & Johnson
Cardinal Health
CareFusion
Celgene
Cellnovo
Celsus Laboratories
CeQur
China Aoxing
CME Medical
Codman and Shurtleff
Collegium
Conmed Corporation
Cook Medical
Covidien
D. Medical Industries
Danone Nutricia
Debiotech
DePuy (acquired by Johnson & Johnson)
Disetronic (acquired by Roche)
Durect
Eli Lilly
Emco
Emisphere
Endo Pharmaceuticals
Fresenius Kabi
GE Medical
Generex Biotechnology Corporation
GlaxoSmithKline (GSK)
Glycologic
Hanraj Nayyar
Hospira
IBM
I-Flow
Insulet Corporation
Intercell
Johnson & Johnson
Kimberly Clark Corporation
Medingo (acquired by Roche)
MedSolve Technologies
Medtronic
Merck KGaA
Micrel Medical Devices
Moog
NeoDevices
Nestle Healthcare
NiliMEDIX (acquired by D. Medical Industries)
Novartis
Noven
Novo Nordisk
Pacira Pharmaceuticals
Pain Therapeutics
Paion AG
Pfizer
Pharmaco-Kinesis Corporation
Philips Medical
pSivida Corporation
Purdue Pharma
Q Core Medical
QRxPharma
Roche
Sanofi
Schiller
Shire
Smiths Medical
SOOIL
Styker
Summit Medical Products
Symbios Medical Products
Takeda
Tandem Diabetes Care
Tandem Diagnostics
Terumo
Trivitron
Valeritas
Vectura
Vishal Surgical
WalkMed
Zevex (acquired by Moog)
Zogenix
Other Organisations Mentioned in this Report
Agência Nacional de Vigilância Sanitária (ANVISA)
American Diabetes Association
Asan Medical Centre
Boston University
Cambridge University
Canadian Diabetes Association
Catholic St. Mary's Hospital
Center for Devices and Radiological Health (CDRH)
Centres for Medicare and Medicaid Service (CMS)
China's Ministry of Science and Technology
China's National Health and Planning Commission (NHPC)
Council of Europe
EU National Competent Authorities (NCAs)
European Association of Urology (EAU)
European Medicines Agency (EMA)
France High Authority of Health
Indiana University School of Medicine
International Diabetes Federation (IDF)
International Organization for Standardization (ISO)
Juvenile Diabetes Research Federation (JDRF)
Medicines and Healthcare products Regulatory Agency (MHRA)
National Health Service (NHS)
National Institute for Health and Clinical Excellence (NICE)
Ningbo First Hospital
Oregon Health & Science University
Pharmaceuticals and Medical Devices Agency (PMDA)
Rashtriya Swasthya Bima Yojana (RSBY)
Roszdravnadzor
Russian Ministry of Industry and Trade (Minpromtorg)
Samsung Medical Centre
Sansum Diabetes Research Institute
Seoul National University Hospital
Servicio Sanitario Nazionale (SSN)
Sistema Único de Saúde (SUS)
South Korea’s Ministry of Health and Welfare (MOHW)
South Korea's Ministry of Science, ICT and Future Planning (MSIP)
South Korea's Ministry of Trade, Industry and Energy (MOTIE)
Stanford University
The American Diabetes Association
The Central Drug Standard Control Organisation (CDSCO)
The Ministry of Health, Labour and Welfare (MHLW)
United Nations (UN)
University of California Santa Barbara
US Department of Health and Human Services
US Food and Drug Administration (FDA)
US Group Purchasing Organisations (GPOs)
US Institutional Review Board (IRB)
World Health Organization (WHO)
World Trade Organization (WTO)
Yonsei Medical Centre
Zhejiang Hospital
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
